Checkpoint Systems RFID to overhaul fast-food dining operations in France with roll-out of reusable tableware RFID Technology Checkpoint Systems RFID to overhaul fast-food dining operations in France with roll-out of reusable tableware RFID Technology PR Newswire PHILADELPHIA, July 5, 2023...
Checkpoint Systems set to showcase new solutions at NRF Protect 2023 Checkpoint Systems set to showcase new solutions at NRF Protect 2023 PR Newswire PHILADELPHIA, May 10, 2023 PHILADELPHIA, May 10, 2023 /PRNewswire/ -- Checkpoint Systems, one of the only vertically integrated RF/RFID solution...
- Checkpoint reveals new RF label that slashes shrink on metallic items by up to 50%
Checkpoint reveals new RF label that slashes shrink on metallic items by up to 50%
PR Newswire THOROFARE, N.J., May 2, 2022 First of its kind security label will enable
retailers to effectively protect metallic...
- MIT Technology Review appoints three new Board members, names two co-chairs MIT
Technology Review appoints three new Board members, names two co-chairs PR Newswire
CAMBRIDGE, Mass., April 4, 2022 CAMBRIDGE, Mass., April 4, 2022 /PRNewswire/ --
Today MIT Technology Review announced the recomposition...
- Security labels that balance sales and sustainability Security labels that balance
sales and sustainability Checkpoint Systems reveals its security labels can be fully
recycled as part of the household paper-based recycling stream PR Newswire THOROFARE,
N.J., March 3, 2022 THOROFARE, N.J., March 3...
- Checkpoint Announced as a Title Sponsor of the 2022 FMI Asset Protection & Grocery
Resilience Conference in Orlando Checkpoint Announced as a Title Sponsor of the
2022 FMI Asset Protection & Grocery Resilience Conference in Orlando March 21-24,
2022 Join Checkpoint Systems as they...
- 'What has Changed in Omnichannel Retail? In 2020: everything. What has Changed in
Omnichannel Retail? In 2020: everything. Checkpoint Systems takes a closer look
at what has changed in the omnichannel retail landscape seemingly overnight due
to the pandemic PR Newswire THOROFARE, N.J., Feb. 12, 2021 ...'
In an informed scientific decision, Heat Biologics new lung cancer trial to include checkpoint inhibitors; Long-term vision sees possible increase in efficacy, with toxic side effects reduced; Combining cancer vaccines with checkpoint inhibitors is gaining clinical momentum; Whether both modalities together lead to success hangs in the balance; in the meantime, Heat may need cash; Change in clinical trial design is intended to boost shareholder value through better outcomes
NEW YORK, NY / ACCESSWIRE / September 18, 2015 / Heat Biologics (HTBX:NASDAQ), in a move motivated by delivering the best clinical results in treatment for non-small cell lung cancer (NSCLC), made an informed scientific move to follow a new initiative.
- Heat is the first to combine a cancer vaccine with a checkpoint inhibitor for NSCLC,
although others are exploring hopes that a multi-based therapy would increase efficacy
without bad side effects seen with PD-1 targeted drugs.
- Later, Heat found that patients in its trial for bladder cancer using HS-410 did
better when low levels of lymphocytes, another key component of human immunity,
were detected, leading researchers to conclude that cancer vaccines could boost
T-cell production and, in combination with checkpoint inhibitors, increase the otherwise
poor numbers of responders with checkpoint inhibitors alone, currently 30%-40% of
- With enrollment in DURGA underway, Heat is ahead of NewLink as the first biotech
to use a vaccine with a checkpoint inhibitor in lung cancer.
- Heat viewed this as support for shifting clinical focus in its NSCLC trial and in
addition to Opdivo, plans to study Merck & Co.'s (MRK:NYSE) Keytruda, another potent
checkpoint inhibitor, with HS-110 when Keytruda gets approval for lung cancer (Keytruda
received Breakthrough Therapy designation from the FDA last October, stressing clinical
recognition of the strength of this drug class).